 |
PDBsum entry 1v3a
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structure of human prl-3, The phosphatase associated with cancer metastasis.
|
 |
|
Authors
|
 |
K.A.Kim,
J.S.Song,
J.Jee,
M.R.Sheen,
C.Lee,
T.G.Lee,
S.Ro,
J.M.Cho,
W.Lee,
T.Yamazaki,
Y.H.Jeon,
C.Cheong.
|
 |
|
Ref.
|
 |
FEBS Lett, 2004,
565,
181-187.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
PRL-3, a novel class protein of prenylated tyrosine phosphatase, is important in
cancer metastasis. Due to its high levels of expression in metastatic tumors,
PRL-3 may constitute a useful marker for metastasis and might be a new
therapeutic target. Here, we present the solution structure of the phosphatase
domain of a human PRL-3 (residues 1-162) in phosphate-free state. The nuclear
magnetic resonance (NMR) structure of PRL-3 is similar to that of other known
phosphatases with minor differences in the secondary structure. But the
conformation and flexibility of the loops comprising the active site differ
significantly. When phosphate ions or sodium orthovanadate, which is a known
inhibitor, are added to the apo PRL-3, the NMR signals from the residues in the
active site appeared and could be assigned, indicating that the conformation of
the residues has been stabilized.
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. A comparison of three structures. (A) PRL-3, (B)
PAC-1, and (C) PTEN. Residues Cys104 and Arg110 of PRL-3 are
marked by filled circles. Asp72 in the general acid loop of
PRL-3 and the corresponding residues in PAC-1 and PTEN are shown
using a ball-and-stick model.
|
 |
Figure 4.
Fig. 4. Overlapping ^1H–^15N HSQC spectra of PRL-3
obtained in the presence and absence of ligand ions. The peaks
representing the free form of the protein are shown in black.
(A) 0.7 mM PRL-3 with 2 mM sodium orthovanadate (brown), (B) 0.7
mM PRL-3 with 20 mM phosphate (purple). The red circled peaks
are the backbone amide protons that appeared in the active site
(phosphate loop).
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the Federation of European Biochemical Societies:
FEBS Lett
(2004,
565,
181-187)
copyright 2004.
|
 |
|
|
|
|
 |